Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.
about
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationThe use of antiarrhythmics prior to cardioversion or catheter ablation for atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationThe use of antiarrhythmics prior to cardioversion or catheter ablation for atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Rationale and current perspective for early rhythm control therapy in atrial fibrillation.Role for myosin-V motor proteins in the selective delivery of Kv channel isoforms to the membrane surface of cardiac myocytes2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.Cytochrome P450-2D6 Genotype Definition May Improve Therapy for Paroxysmal Atrial Fibrillation A Case of Syncope Following "Pill-in-the-Pocket" Quinidine plus Propafenone.Can we improve outcomes in AF patients by early therapy?An Observational, Prospective Survey Assessing the Control of Atrial Fibrillation in Asia Pacific: Rationale and Design of the RecordAF-AP Registry.Dofetilide: a new class III antiarrhythmic agent.Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.Déjà vu in the theories of atrial fibrillation dynamics.Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study.The Future of Pulmonary Vein Isolation - Single-shot Devices, Remote Navigation or Improving Conventional Radiofrequency Delivery by Contact Monitoring and Lesion Characterisation?Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial.Polyunsaturated Fatty acids in atrial fibrillation: looking for the proper candidates.Drug therapy in atrial fibrillation management: where do we stand in 2010?Risk Stratification in Atrial Fibrillation Patients - A Review Focused on Mortality.The hERG potassium channel as a therapeutic target.All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control studyManagement of the Asymptomatic Patient After Catheter Ablation of Atrial FibrillationSafe use of SSRIs in young adults: how strong is evidence for new suicide warning?Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.Effects of CYP2D6 genotypes on age-related change of flecainide metabolism: involvement of CYP1A2-mediated metabolism.Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progression.The Role Of Renin Angiotensin System In Atrial Fibrillation.Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.Angiotensin II receptor blockers in the prevention of atrial fibrillation.Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil.Optimizing the management of atrial fibrillation: focus on current guidelines and the impact of new agents on future recommendations.Rhythm control strategies and the role of antiarrhythmic drugs in the management of atrial fibrillation: focus on clinical outcomes.Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.Sinus rhythm restoration and treatment success: insight from recent clinical trials.Prevention of recurrent atrial fibrillation with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a systematic review and meta-analysis of randomized trials.Treating arrhythmias: an expert opinion.Catheter ablation of atrial fibrillation guided by electrogram fractionation and dominant frequency analysis.
P2860
Q24187110-06AB04E6-FDC5-49CF-A003-4D629ECB13C1Q24188262-7B158BBF-C838-4821-B90B-6DB46DB250CFQ24197643-92500881-C80B-41CD-8467-D1A7EF13599EQ24201163-EE0A0119-F8F1-4D99-9F8A-09237C1F9C09Q24243067-EF0AB9B8-7E91-40A5-B79B-924099F2F2C7Q27341873-2A73C8FE-C7FC-43BA-92E2-C777A82B20A8Q27692632-7DBB4949-E051-47B5-92A3-E3E7AC752980Q28565984-0272EB8D-D36A-4D6C-AA0B-63B7B103F683Q30653045-2BBF8EF0-D10E-496B-98D3-56D619613C6CQ33168000-09842C16-D81E-4AC7-99C4-E557211099D3Q33516708-466A0950-3697-4FAD-AE4B-0B5A64FB1C39Q34583506-8471C341-0685-4271-B0C7-CD979AC22225Q34594440-433A964C-3F95-40B6-9EE6-A99FF8539B32Q34609020-2645E938-FA83-43AB-85F4-D45FB8CF9A80Q35018357-5A64B661-63D5-435F-ADCD-B247B86EFE74Q35143132-2CADE80F-1913-4865-AD16-E86C3629E79AQ35911652-0768C0AE-8237-477D-A589-638EB04EDB25Q35926637-6ED3F80E-E189-482B-9937-FC559B3AD83FQ36254295-4D380BA0-7301-4C59-9AB0-F999CC38D856Q36305013-35C1FB0C-0F49-4A93-843C-443F048168ACQ36458898-BB9DD3D2-454B-4802-800B-CE561B5FF3D1Q36734932-9AC9852A-30C5-462B-9C43-69491206CEEBQ36746225-1E55160D-DE08-4BEE-BE57-A6EEB43248D1Q37115340-7F7D175A-25DB-4A48-AB77-525FF937547AQ37173314-B0CF70C9-3B2D-4D5D-B7CF-7B52EDEFC9DEQ37246263-C2DF770C-CAAA-413F-B47A-412BA6880D8EQ37321429-2278BBB4-BFBD-4DF2-AEA1-E30E4FE7DED9Q37412467-02495C13-CF97-43D7-8CF5-0B12EE8CE1F9Q37469038-D737D76D-7610-49F6-B31F-F513DFDC3EFEQ37472036-C0EAD0D4-3490-4292-8F9C-4746BAF55EA7Q37494662-A4405C29-2310-4528-861D-41A71A293BDBQ37521378-1F0CB123-FDE0-4F09-839E-AB4EF062CE19Q37551914-2F5BC064-2B29-4755-BFF7-380A39677883Q37766393-90A0B2D1-D4D4-4402-8961-05447ADD043DQ37812344-6D03FD1F-C2C1-4C7D-A3DA-B0E00DF66053Q37815205-D84267B8-696E-49B6-8403-D9C728A00E9DQ37831854-0AB3BE77-D6BD-451D-9225-B20B15DCE24EQ37834181-EA3B30AA-0781-4612-9940-DD84E8BE289EQ37847185-C3F225D5-E7C5-4306-9013-542B7D63B671Q37880141-27DB00B3-8475-4316-8C88-0C9E056BB520
P2860
Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Antiarrhythmic drugs for maint ...... randomized controlled trials.
@ast
Antiarrhythmic drugs for maint ...... randomized controlled trials.
@en
type
label
Antiarrhythmic drugs for maint ...... randomized controlled trials.
@ast
Antiarrhythmic drugs for maint ...... randomized controlled trials.
@en
prefLabel
Antiarrhythmic drugs for maint ...... randomized controlled trials.
@ast
Antiarrhythmic drugs for maint ...... randomized controlled trials.
@en
P2093
P1476
Antiarrhythmic drugs for maint ...... randomized controlled trials.
@en
P2093
Isabelle Mahé
Miguel Angel Longás-Tejero
Stéphane Mouly
P304
P356
10.1001/ARCHINTE.166.7.719
P407
P577
2006-04-01T00:00:00Z